Literature DB >> 23657852

Obesity-metabolic derangement preserves hemodynamics but promotes intrarenal adiposity and macrophage infiltration in swine renovascular disease.

Xin Zhang1, Zi-Lun Li, John R Woollard, Alfonso Eirin, Behzad Ebrahimi, John A Crane, Xiang-Yang Zhu, Aditya S Pawar, James D Krier, Kyra L Jordan, Hui Tang, Stephen C Textor, Amir Lerman, Lilach O Lerman.   

Abstract

Obesity-metabolic disorders (ObM) often accompany renal artery stenosis (RAS). We hypothesized that the coexistence of ObM and RAS magnifies inflammation and microvascular remodeling in the stenotic kidney (STK) and aggravates renal scarring. Twenty-eight obesity-prone Ossabaw pigs were studied after 16 wk of a high-fat/high-fructose diet or standard chow including ObM-sham, ObM-RAS, Lean-RAS, or Lean-sham (normal control) groups. Single-kidney renal blood flow (RBF) and glomerular filtration rate (GFR) were assessed by multidetector computed tomography (CT), renal oxygenation and tubular transport capability by blood-oxygen-level-dependent MRI, and microcirculation by micro-CT for vessel density, and Western blotting for protein expressions of angiogenic factors (VEGF/FLK-1). Renal vein and inferior vena cava levels of inflammatory cytokines were measured to evaluate systemic and kidney inflammation. Macrophage (MØ) infiltration and subpopulations, fat deposition in the kidney, and inflammation in perirenal and abdominal fat were also examined. GFR and RBF were decreased in Lean-STK but relatively preserved in ObM-STK. However, ObM-STK showed impaired tubular transport function, suppressed microcirculation, and stimulated glomerulosclerosis. ObM diet interacted with RAS to blunt angiogenesis in the STK, facilitated the release of inflammatory cytokines, and led to greater oxidative stress than Lean-STK. The ObM diet also induced fat deposition in the kidney and infiltration of proinflammatory M1-MØ, as also in perirenal and abdominal fat. Coexistence of ObM and RAS amplifies renal inflammation, aggravates microvascular remodeling, and accelerates glomerulosclerosis. Increased adiposity and MØ-accentuated inflammation induced by an ObM diet may contribute to structural injury in the post-STK kidney.

Entities:  

Keywords:  adiposity; inflammation; macrophage; obesity-metabolic derangement; renal artery stenosis

Mesh:

Substances:

Year:  2013        PMID: 23657852      PMCID: PMC3742861          DOI: 10.1152/ajprenal.00043.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  39 in total

1.  Inflammatory and injury signals released from the post-stenotic human kidney.

Authors:  Alfonso Eirin; Monika L Gloviczki; Hui Tang; Mario Gössl; Kyra L Jordan; John R Woollard; Amir Lerman; Joseph P Grande; Stephen C Textor; Lilach O Lerman
Journal:  Eur Heart J       Date:  2012-07-06       Impact factor: 29.983

Review 2.  Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?

Authors:  Susan P Bagby
Journal:  J Am Soc Nephrol       Date:  2004-11       Impact factor: 10.121

3.  Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: comparison with electron-beam CT.

Authors:  Elena Daghini; Andrew N Primak; Alejandro R Chade; James D Krier; Xiang-Yang Zhu; Erik L Ritman; Cynthia H McCollough; Lilach O Lerman
Journal:  Radiology       Date:  2007-05       Impact factor: 11.105

4.  Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney.

Authors:  Ester González; Eduardo Gutiérrez; Enrique Morales; Eduardo Hernández; Amado Andres; Ignacio Bello; Rafael Díaz-González; Oscar Leiva; Manuel Praga
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

Review 5.  Scope and mechanisms of obesity-related renal disease.

Authors:  Tracy E Hunley; Li-Jun Ma; Valentina Kon
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

Review 6.  Macrophage diversity in renal injury and repair.

Authors:  Sharon D Ricardo; Harry van Goor; Allison A Eddy
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

Review 7.  Angiogenesis in the kidney: a new therapeutic target?

Authors:  Lilach O Lerman; Alejandro R Chade
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-03       Impact factor: 2.894

8.  Cortical microvascular remodeling in the stenotic kidney: role of increased oxidative stress.

Authors:  Xiang-Yang Zhu; Alejandro R Chade; Martin Rodriguez-Porcel; Michael D Bentley; Erik L Ritman; Amir Lerman; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-12       Impact factor: 8.311

Review 9.  Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond.

Authors:  Lilach O Lerman; Stephen C Textor; Joseph P Grande
Journal:  Prog Cardiovasc Dis       Date:  2009 Nov-Dec       Impact factor: 8.194

10.  Antioxidant intervention blunts renal injury in experimental renovascular disease.

Authors:  Alejandro R Chade; Martin Rodriguez-Porcel; Joerg Herrmann; Xiangyang Zhu; Joseph P Grande; Claudio Napoli; Amir Lerman; Lilach O Lerman
Journal:  J Am Soc Nephrol       Date:  2004-04       Impact factor: 10.121

View more
  27 in total

Review 1.  Obesity and renovascular disease.

Authors:  Xin Zhang; Lilach O Lerman
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-03

2.  Coexisting renal artery stenosis and metabolic syndrome magnifies mitochondrial damage, aggravating poststenotic kidney injury in pigs.

Authors:  Arash Aghajani Nargesi; Lihong Zhang; Hui Tang; Kyra L Jordan; Ishran M Saadiq; Stephen C Textor; Lilach O Lerman; Alfonso Eirin
Journal:  J Hypertens       Date:  2019-10       Impact factor: 4.844

3.  Obesity-metabolic derangement exacerbates cardiomyocyte loss distal to moderate coronary artery stenosis in pigs without affecting global cardiac function.

Authors:  Zi-Lun Li; Behzad Ebrahimi; Xin Zhang; Alfonso Eirin; John R Woollard; Hui Tang; Amir Lerman; Shen-Ming Wang; Lilach O Lerman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-07       Impact factor: 4.733

4.  Low-Energy Shockwave Therapy Improves Ischemic Kidney Microcirculation.

Authors:  Xin Zhang; James D Krier; Carolina Amador Carrascal; James F Greenleaf; Behzad Ebrahimi; Ahmad F Hedayat; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  J Am Soc Nephrol       Date:  2016-06-13       Impact factor: 10.121

Review 5.  Diagnostic imaging in the management of patients with metabolic syndrome.

Authors:  Seo Rin Kim; Lilach O Lerman
Journal:  Transl Res       Date:  2017-11-22       Impact factor: 7.012

6.  The metabolic syndrome induces early changes in the swine renal medullary mitochondria.

Authors:  Alfonso Eirin; John R Woollard; Christopher M Ferguson; Kyra L Jordan; Hui Tang; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Transl Res       Date:  2017-03-11       Impact factor: 7.012

7.  Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation.

Authors:  Alfonso Eirin; Xiang-Yang Zhu; Amrutesh S Puranik; Hui Tang; Kelly A McGurren; Andre J van Wijnen; Amir Lerman; Lilach O Lerman
Journal:  Kidney Int       Date:  2017-02-24       Impact factor: 10.612

8.  Renal Vein Levels of MicroRNA-26a Are Lower in the Poststenotic Kidney.

Authors:  Xiang-Yang Zhu; Behzad Ebrahimi; Alfonso Eirin; John R Woollard; Hui Tang; Kyra L Jordan; Michael Ofori; Ahmed Saad; Sandra M S Herrmann; Allan B Dietz; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

9.  Cardiac metabolic alterations in hypertensive obese pigs.

Authors:  Xin Zhang; Zi-Lun Li; Alfonso Eirin; Behzad Ebrahimi; Aditya S Pawar; Xiang-Yang Zhu; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2015-06-15       Impact factor: 10.190

10.  Renal Adiposity Confounds Quantitative Assessment of Markers of Renal Diffusion With MRI: A Proposed Correction Method.

Authors:  Behzad Ebrahimi; Ahmed Saad; Kai Jiang; Christopher M Ferguson; Hui Tang; John R Woollard; James F Glockner; Stephen C Textor; Lilach O Lerman
Journal:  Invest Radiol       Date:  2017-11       Impact factor: 6.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.